FR2295741B1 - - Google Patents

Info

Publication number
FR2295741B1
FR2295741B1 FR7531075A FR7531075A FR2295741B1 FR 2295741 B1 FR2295741 B1 FR 2295741B1 FR 7531075 A FR7531075 A FR 7531075A FR 7531075 A FR7531075 A FR 7531075A FR 2295741 B1 FR2295741 B1 FR 2295741B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7531075A
Other versions
FR2295741A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk GmbH filed Critical Steigerwald Arzneimittelwerk GmbH
Publication of FR2295741A1 publication Critical patent/FR2295741A1/fr
Application granted granted Critical
Publication of FR2295741B1 publication Critical patent/FR2295741B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
FR7531075A 1974-12-28 1975-10-10 Derives de la pyridoxine, leur procede de preparation et leur application Granted FR2295741A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2461742A DE2461742C2 (de) 1974-12-28 1974-12-28 Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2295741A1 FR2295741A1 (fr) 1976-07-23
FR2295741B1 true FR2295741B1 (fr) 1979-09-14

Family

ID=5934705

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7531075A Granted FR2295741A1 (fr) 1974-12-28 1975-10-10 Derives de la pyridoxine, leur procede de preparation et leur application

Country Status (2)

Country Link
DE (1) DE2461742C2 (fr)
FR (1) FR2295741A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705549A1 (de) * 1987-02-18 1988-09-01 Ulrich Speck Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose
DE4016963A1 (de) * 1990-05-25 1991-11-28 Steigerwald Arzneimittelwerk Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben
US6228858B1 (en) 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
AU1444600A (en) * 1998-10-09 2000-05-01 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (fr) 1999-08-24 2001-03-01 Medicure International Inc. Traitement des pathologies cardio-vasculaires et connexes
DE60110054T2 (de) 2000-02-29 2006-03-09 Medicure International Inc. Cardioprotektive phosphonate
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
WO2006050598A1 (fr) 2004-10-28 2006-05-18 Medicure International Inc. Analogues de pyridoxine à double activité anti-plaquettes et anti-coagulantes
US7375112B2 (en) * 2005-01-05 2008-05-20 Medicure International Inc. Compounds and methods for regulating triglyceride levels
US20060183803A1 (en) * 2005-02-17 2006-08-17 Instituto Del Metabolismo Celular, S.L. L-aspartic acid for the treatment of assorted health problems

Also Published As

Publication number Publication date
FR2295741A1 (fr) 1976-07-23
DE2461742A1 (de) 1976-07-08
DE2461742C2 (de) 1983-01-27

Similar Documents

Publication Publication Date Title
FR2282911B3 (fr)
FR2284567B1 (fr)
FR2256878B3 (fr)
FR2261800A1 (fr)
DK12675A (fr)
FR2295741B1 (fr)
FR2260581A1 (fr)
FR2279493B1 (fr)
FR2265539B1 (fr)
AU495930B2 (fr)
FR2267207B3 (fr)
FR2263698A1 (fr)
CH566915A5 (fr)
AU479765A (fr)
AU480247A (fr)
AU480471A (fr)
DD121066A5 (fr)
DD117268A5 (fr)
AU479931A (fr)
CH592240A5 (fr)
CH569666A5 (fr)
CH569220A5 (fr)
CH568539A5 (fr)
CH568134A5 (fr)
BG21352A1 (fr)